A comparison of clinical outcomes between Canadian and American patients after nonurgent coronary stenting

Canadian Journal of Cardiology

Volumn 20, Issue 13, 2004, Pages 1343-1349

  Madan, Mina ^a   Labinaz, Marino ^b   Cohen, Eric A ^a   Buller, Christopher E ^c   Cantor, Warren J ^d   Seidelin, Peter ^e   Ducas, John ^f   Carere, Ronald G ^g   Natarajan, Madhu K ^h   Pieper, Karen S ⁱ   Hafley, Gail E ⁱ   O'Shea, J Conor ⁱ   Kitt, Michael M ^j   Califf, Robert M ⁱ   Tcheng, James E ⁱ  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f HEALTH SCIENCES CENTRE   (Canada)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ DUKE UNIVERSITY MEDICAL CENTER   (United States)

^j MILLENNIUM PHARMACEUTICALS INC   (United States)

more..

Author keywords

Canada; Stents; United States

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EPTIFIBATIDE; HEPARIN; PLACEBO; TICLOPIDINE;

ADULT; AGE; ARTERY DISSECTION; ARTERY EMBOLISM; ARTICLE; BODY WEIGHT; CANADA; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DRUG EFFICACY; FEMALE; GEOGRAPHY; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; THROMBUS; TREATMENT OUTCOME; UNITED STATES;

EID: 10644253694     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Mark DB, Naylor CD, Hlatky MA, et al. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States, N Engl J Med 1994;331:1130-5.
2. Batchelor WB, Peterson ED, Mark DB, et al. A comparison of US and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: Efficiency, yield, and long-term implications. J Am Coll Cardiol 1999;34:12-9.
3. Pilote L, Bourassa MG, Bacon C, et al. Better functional status in American than Canadian patients with heart disease: An effect of medical care? J Am Coll Cardiol 1995;26:1115-20.
4. Pilote L, Racine N, Hlatky MA. Differences in the treatment of myocardial infarction in the United States and Canada. A comparison of two university hospitals. Arch Intern Med 1994;154:1090-6.
5. Bourassa MG, Brooks MM, Mark DB, et al. Quality of life after coronary revascularization in the United States and Canada. Am J Cardiol 2000;85:548-53.
6. Rouleau JL, Moye LA, Pfeffer MA, et al. A comparison of management patterns after myocardial infarction in Canada and the United States. The SAVE investigators. N Engl J Med 1993;328:779-84.
7. Anderson HV, Gibson RS, Stone PH, et al. Management of unstable angina pectoris and non-Q-wave acute myocardial infarction in the United States and Canada (the TIMI-III Registry). Am J Cardiol 1997;79:1441-6.
8. O'Shea JC, Fu Y, Chang WC, Armstrong PW. A tale of two countries: Insights from the differences in Canadian/American patterns of care for patients with acute coronary syndromes. Am Heart J 2001;142:14-20.
9. Eisenberg MJ, Califf RM, Cohen EA, Adelman AG, Mark DB, Topol EJ. Use of evidence-based medical therapy in patients undergoing percutaneous coronary revascularization in the United States, Europe, and Canada. Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I) and Canadian Coronary Atherectomy Trial (CCAT) investigators. Am J Cardiol 1997;79:867-72.
10. The ESPRIT Investigators. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): A randomised, placebo-controlled trial. Lancet 2000;356:2037-44 (Erratum in 2001;357:1370).
11. O'Shea JC, Cohen EA, Buller CE, et al. Predictors of improvement in clinical outcomes of non-acute coronary stenting in the ESPRIT trial. Circulation 2000;102:II-665. (Abst)
12. The EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 1998;352:87-92.
13. Fu Y, Chang WC, Mark D, et al. Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: One-year follow-up of patients without ST-segment elevation. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) II Investigators. Circulation 2000;102:1375-81.
14. Chang WC, Fu Y, Ohman EM, et al. Temporal evolution in the management of acute ST elevation myocardial infarction: The seven-year GUSTO experience from Canada and the United States. The North American GUSTO-I and GUSTO-III Investigators. Can J Cardiol 2000;16:1231-9.
15. Yusuf S, Flather M, Pogue J, et al, for the OASIS Registry Investigators. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction. without initial ST elevation. Lancet 1998;352:507-14.
16. Tu JV, Pashos CL, Naylor CD, et al. Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. N Engl J Med 1997;336:1500-5 (Erratum in 1997;337:139).
17. Cohen EA, Lincoff M, Sapp S, et al. Variations in event rates between Canada and the United States in the EPISTENT trial. J Am Coll Cardiol 2001;37(Suppl A):81A. (Abst)
18. Steinhubl SR, Berger PB, Mann JT III, et al; CREDO Investigators. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA 2002;288:2411-20 (Erratum in 2003;289:987).
19. Ellis SG, Weintraub W, Holmes D, Shaw R, Block PC, King SB III. Relation of operator volume and experience to procedural outcome of percuraneous coronary revascularization at hospitals with high interventional volumes. Circulation 1997;95:2479-84.
20. Hannan EL, Racz M, Ryan TJ, et al. Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. JAMA 1997;277:892-8.
21. Smith SC Jr, Dove JT, Jacobs AK, et al; American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty); Society for Cardiac Angiography and Interventions. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines) - executive summary: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation 2001;103:3019-41.
22. Cardiac Care Network of Ontario. Expert panel on invasive cardiology in Ontario: Final report and recommendations (June 2001). (Version current at September 27, 2004).
23. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000;284:835-42.